Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

Entinostat (MS-275) - HDAC Inhibitor. CAS# 209783-80-2 0166 S3I-201 inhibits breast carcinoma MDA-MB-435

SKU: 52611325552

4.0
SEK39.00 SEK79.00

Pay in 4 interest-free payments of $9.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Live Spec

Entinostat (MS-275) - HDAC Inhibitor. CAS# 209783-80-2 0166 S3I-201 inhibits breast carcinoma MDA-MB-435Entinostat (MS 275), CAS No. 209783 80 2, is a potent and selective HDAC inhibitor. It inhibits HDAC1 and HDAC3 with IC50 of 0. 51 M and 1. 7 M, but not the other HDACs 4, 6, 8, and 10 (IC50 > 100 M). MS 275 induces accumulation of p21WAF1 CIP1 and gelsolin in K562 cell. It was shown to reduce S phase cells and induce G1 phase cells in A2780 cells. MS 275 shows great inhibition to human leukemia and lymphoma cells, decreases expression of cyclin D1

Store: matisco.be · Domain: matisco.be

Description

S3I-201 inhibits breast carcinoma MDA-MB-435

ITD-1 was used at 5 µM final concentration in vitro and in cellular assays

and DNA-PK

It was dosed to diabetic ob/ob mice via oral gavage at 3-30 mg/kg once per day for 2 weeks

Entinostat (MS-275) - HDAC Inhibitor. CAS# 209783-80-2 0166 S3I-201 inhibits breast carcinoma MDA-MB-435Entinostat (MS 275), CAS No. 209783 80 2, is a potent and selective HDAC inhibitor. It inhibits HDAC1 and HDAC3 with IC50 of 0. 51 M and 1. 7 M, but not the other HDACs 4, 6, 8, and 10 (IC50 > 100 M). MS 275 induces accumulation of p21WAF1 CIP1 and gelsolin in K562 cell. It was shown to reduce S phase cells and induce G1 phase cells in A2780 cells. MS 275 shows great inhibition to human leukemia and lymphoma cells, decreases expression of cyclin D1

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products